170 related articles for article (PubMed ID: 10413462)
21. Role of the 207-218 peptide region of Moloney murine leukemia virus integrase in enzyme catalysis.
Acevedo ML; Arbildúa JJ; Monasterio O; Toledo H; León O
Arch Biochem Biophys; 2010 Mar; 495(1):28-34. PubMed ID: 20026028
[TBL] [Abstract][Full Text] [Related]
22. Sequence specificity of viral end DNA binding by HIV-1 integrase reveals critical regions for protein-DNA interaction.
Esposito D; Craigie R
EMBO J; 1998 Oct; 17(19):5832-43. PubMed ID: 9755183
[TBL] [Abstract][Full Text] [Related]
23. Large-scale conformational dynamics of the HIV-1 integrase core domain and its catalytic loop mutants.
Lee MC; Deng J; Briggs JM; Duan Y
Biophys J; 2005 May; 88(5):3133-46. PubMed ID: 15731379
[TBL] [Abstract][Full Text] [Related]
24. Similarities in the HIV-1 and ASV integrase active sites upon metal cofactor binding.
Lins RD; Straatsma TP; Briggs JM
Biopolymers; 2000 Apr; 53(4):308-15. PubMed ID: 10685051
[TBL] [Abstract][Full Text] [Related]
25. Structural and dynamical properties of a full-length HIV-1 integrase: molecular dynamics simulations.
Wijitkosoom A; Tonmunphean S; Truong TN; Hannongbua S
J Biomol Struct Dyn; 2006 Jun; 23(6):613-24. PubMed ID: 16615807
[TBL] [Abstract][Full Text] [Related]
26. The structure of truncated recombinant human bile salt-stimulated lipase reveals bile salt-independent conformational flexibility at the active-site loop and provides insights into heparin binding.
Moore SA; Kingston RL; Loomes KM; Hernell O; Bläckberg L; Baker HM; Baker EN
J Mol Biol; 2001 Sep; 312(3):511-23. PubMed ID: 11563913
[TBL] [Abstract][Full Text] [Related]
27. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV.
Hombrouck A; De Rijck J; Hendrix J; Vandekerckhove L; Voet A; De Maeyer M; Witvrouw M; Engelborghs Y; Christ F; Gijsbers R; Debyser Z
PLoS Pathog; 2007 Mar; 3(3):e47. PubMed ID: 17397262
[TBL] [Abstract][Full Text] [Related]
28. Communications: Electron polarization critically stabilizes the Mg2+ complex in the catalytic core domain of HIV-1 integrase.
Lu Y; Mei Y; Zhang JZ; Zhang D
J Chem Phys; 2010 Apr; 132(13):131101. PubMed ID: 20387913
[TBL] [Abstract][Full Text] [Related]
29. Active site binding modes of the beta-diketoacids: a multi-active site approach in HIV-1 integrase inhibitor design.
Dayam R; Neamati N
Bioorg Med Chem; 2004 Dec; 12(24):6371-81. PubMed ID: 15556755
[TBL] [Abstract][Full Text] [Related]
30. On the role of the conformational flexibility of the active-site lid on the allosteric kinetics of glucosamine-6-phosphate deaminase.
Bustos-Jaimes I; Sosa-Peinado A; Rudiño-Piñera E; Horjales E; Calcagno ML
J Mol Biol; 2002 May; 319(1):183-9. PubMed ID: 12051945
[TBL] [Abstract][Full Text] [Related]
31. Identification of the active conformation and the importance of length of the flexible loop 72-83 in regulating the conformational change of undecaprenyl pyrophosphate synthase.
Chang SY; Chen YK; Wang AH; Liang PH
Biochemistry; 2003 Dec; 42(49):14452-9. PubMed ID: 14661956
[TBL] [Abstract][Full Text] [Related]
32. The conserved cis-Pro39 residue plays a crucial role in the proper positioning of the catalytic base Asp38 in ketosteroid isomerase from Comamonas testosteroni.
Nam GH; Cha SS; Yun YS; Oh YH; Hong BH; Lee HS; Choi KY
Biochem J; 2003 Oct; 375(Pt 2):297-305. PubMed ID: 12852789
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of the HIV-1 integrase catalytic core and C-terminal domains: a model for viral DNA binding.
Chen JC; Krucinski J; Miercke LJ; Finer-Moore JS; Tang AH; Leavitt AD; Stroud RM
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8233-8. PubMed ID: 10890912
[TBL] [Abstract][Full Text] [Related]
34. Sequence-based design and discovery of peptide inhibitors of HIV-1 integrase: insight into the binding mode of the enzyme.
Li HY; Zawahir Z; Song LD; Long YQ; Neamati N
J Med Chem; 2006 Jul; 49(15):4477-86. PubMed ID: 16854053
[TBL] [Abstract][Full Text] [Related]
35. Prediction of HIV-1 integrase/viral DNA interactions in the catalytic domain by fast molecular docking.
Adesokan AA; Roberts VA; Lee KW; Lins RD; Briggs JM
J Med Chem; 2004 Feb; 47(4):821-8. PubMed ID: 14761184
[TBL] [Abstract][Full Text] [Related]
36. Structure of human pro-chymase: a model for the activating transition of granule-associated proteases.
Reiling KK; Krucinski J; Miercke LJ; Raymond WW; Caughey GH; Stroud RM
Biochemistry; 2003 Mar; 42(9):2616-24. PubMed ID: 12614156
[TBL] [Abstract][Full Text] [Related]
37. Study on the inhibitory mechanism and binding mode of the hydroxycoumarin compound NSC158393 to HIV-1 integrase by molecular modeling.
Liu M; Cong XJ; Li P; Tan JJ; Chen WZ; Wang CX
Biopolymers; 2009 Sep; 91(9):700-9. PubMed ID: 19382173
[TBL] [Abstract][Full Text] [Related]
38. The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop.
Dekker RJ; Eichinger A; Stoop AA; Bode W; Pannekoek H; Horrevoets AJ
J Mol Biol; 1999 Oct; 293(3):613-27. PubMed ID: 10543954
[TBL] [Abstract][Full Text] [Related]
39. Single amino acid substitution in HIV-1 integrase catalytic core causes a dramatic shift in inhibitor selectivity.
Al-Mawsawi LQ; Sechi M; Neamati N
FEBS Lett; 2007 Mar; 581(6):1151-6. PubMed ID: 17328897
[TBL] [Abstract][Full Text] [Related]
40. Solution structure of the His12 --> Cys mutant of the N-terminal zinc binding domain of HIV-1 integrase complexed to cadmium.
Cai M; Huang Y; Caffrey M; Zheng R; Craigie R; Clore GM; Gronenborn AM
Protein Sci; 1998 Dec; 7(12):2669-74. PubMed ID: 9865962
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
